Ad
Short

Perplexity has introduced "Comet," an AI-powered browser designed to replace traditional tabs with an interface that uses LLMs to help users navigate the web. With Comet, users can write emails, plan meetings, compare products, ask questions, or highlight text to get instant explanations. Perplexity says the goal is to make browsing simpler and give people better access to information. Comet will launch first for Perplexity Max subscribers at $200 per month, with access managed through a waitlist and invitation system starting this summer.

Video: Perplexity

Short

Replit is teaming up with Microsoft to automate app development for non-programmers.

The company is positioning itself as a no-code prototyping platform for business users, promising to turn natural language prompts into working apps - complete with database, authentication, and storage. These applications are available directly through the Azure Marketplace and run on Azure infrastructure managed by Replit.

The partnership is aimed squarely at the prototyping and design market, an area currently dominated by Figma. Replit does not see itself as direct competition for Microsoft's flagship AI tool, GitHub Copilot.

Short

OpenAI and the American Federation of Teachers (AFT) are launching the National Academy for AI Instruction, a five-year initiative aimed at training 400,000 teachers across the United States to use artificial intelligence in the classroom. OpenAI is contributing $10 million to the effort, with $8 million in direct funding and $2 million in technical support. The goal is to help teachers integrate AI into their teaching, with a special focus on underserved school districts.

The project is backed by additional partners, including Microsoft, Anthropic, and the United Federation of Teachers. The first training center is being built in New York City, with plans to open more by 2030. Teachers will have access to workshops, online courses, and hands-on training, along with priority access to OpenAI tools, technical support, and resources to build their own AI-powered classroom applications.

Ad
Ad
Ad
Ad
Short

CoreWeave is set to acquire data center provider Core Scientific in a share swap deal worth about $9 billion. The transaction is expected to close in the fourth quarter of 2025. Core Scientific adds 1.3 gigawatts of existing power capacity, plus more than 1 gigawatt of expansion potential.

CoreWeave, which calls itself an "AI hyperscaler," specializes in cloud infrastructure for compute-intensive AI workloads. By owning its own data centers, the company aims to lower costs and reduce dependence on outside providers as competition heats up in the AI infrastructure market. In March, OpenAI invested $12 billion in CoreWeave. CoreWeave has also reportedly benefited from Microsoft scaling back its own AI data center investments.

Short

Capgemini is investing $3.3 billion to bring generative AI and so-called "agentic AI" into its clients' business operations.

The company plans to acquire WNS, a provider of digital business process services, as part of this push. "Business Process Services will be the showcase for Agentic AI," Capgemini CEO Aiman Ezzat said about the deal. WNS already delivers AI-powered process solutions to companies in eight industries, counting United Airlines and Aviva among its clients.

Capgemini and WNS say the goal is to become a leader in intelligent operations by using autonomous AI to fundamentally rethink how businesses run their core processes.

Ad
Ad
Short

Isomorphic Labs, a Deepmind spin-off focused on drug discovery, is getting ready for its first clinical trials with drugs designed using AlphaFold-based AI models.

"We're staffing up now. We're getting very close," said Colin Murdoch, President of Isomorphic Labs and Chief Business Officer at Deepmind, in an interview with Fortune.

The company wants to overhaul the traditionally slow and expensive process of drug development, with anti-cancer drugs already in the pipeline. Isomorphic Labs has signed agreements with Eli Lilly and Novartis, and in 2025 closed a USD 600 million investment round led by Thrive Capital.

Looking ahead, Isomorphic Labs has even bigger ambitions for AI in medicine. "One day we hope to be able to say— well, here's a disease, and then click a button and out pops the design for a drug to address that disease," Murdoch said.

Google News